Work

Chemotherapy of leishmaniasis: present challenges

Year: 2017
Type: review
Abstract: Cutaneous and visceral leishmaniasis are amongst the most devastating infectious diseases of our time, affecting millions of people worldwide. The treatment of these serious diseases rely on a few chemotherapeutic agents, most of which are of parenteral use and induce severe side-effects. Furthermore, rates of treatment failure are high and have been linked to drug resistance in some areas. Here, we reviewed data on current chemotherapy practice in leishmaniasis. Drug resistance and mechanisms of resistance are described as well as the prospects for applying drug combinations for leishmaniasis chemotherapy. It is clear that efforts for discovering new drugs applicable to leishmaniasis chemotherapy are essential. The main aspects on the various steps of drug discovery in the field are discussed.
Source: Parasitology
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,550
OpenAlex ID: W2573547936
FWCI: 3.529
Cites: 222
Cited by: 292
Related to: 10